Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Chien-Chung Yang & Chuen-Mao Yang. (2021) Chinese Herbs and Repurposing Old Drugs as Therapeutic Agents in the Regulation of Oxidative Stress and Inflammation in Pulmonary Diseases. Journal of Inflammation Research 14, pages 657-687.
Read now
Read now
Articles from other publishers (30)
Fanfan Liang, Kaina Zhang, Wenzhuo Ma, Heqin Zhan, Qiang Sun, LaiHua Xie & Zhenghang Zhao. (2022) Impaired autophagy and mitochondrial dynamics are involved in Sorafenib-induced cardiomyocyte apoptosis. Toxicology 481, pages 153348.
Crossref
Crossref
Jaeseong Jeong & Jinhee Choi. (2022) Advancing the Adverse Outcome Pathway for PPARγ Inactivation Leading to Pulmonary Fibrosis Using Bradford-Hill Consideration and the Comparative Toxicogenomics Database. Chemical Research in Toxicology 35:2, pages 233-243.
Crossref
Crossref
Shuxin Li, Hongmin Zhang, Jing Chang, Dongming Li & Pengxiu Cao. (2021) Iron overload and mitochondrial dysfunction orchestrate pulmonary fibrosis. European Journal of Pharmacology 912, pages 174613.
Crossref
Crossref
Qingzhong Hua, Xiaoting Huang, Weixi Xie, Feiyan Zhao, Haipeng Cheng, Ziqiang Luo, Jianzhong Han, Zun Wang, Qian Zeng, Miao Lin, Tingting Zhou, Jialu Zhang, Can Gu, Wei Liu & Siyuan Tang. (2021) PPARγ mediates the anti-pulmonary fibrosis effect of icaritin. Toxicology Letters 350, pages 81-90.
Crossref
Crossref
Yu Hu, JianHua Fu, XueYan Liu & XinDong Xue. (2020) ERK1/2 Signaling Pathway Activated by EGF Promotes Proliferation, Transdifferentiation, and Migration of Cultured Primary Newborn Rat Lung Fibroblasts. BioMed Research International 2020, pages 1-9.
Crossref
Crossref
Yves Lecarpentier, Elizabeth Gourrier, Vincent Gobert & Alexandre Vallée. (2019) Bronchopulmonary Dysplasia: Crosstalk Between PPARγ, WNT/β-Catenin and TGF-β Pathways; The Potential Therapeutic Role of PPARγ Agonists. Frontiers in Pediatrics 7.
Crossref
Crossref
Yu Hu, Jianhua Fu & Xindong Xue. (2018) Association of the proliferation of lung fibroblasts with the ERK1/2 signaling pathway in neonatal rats with hyperoxia‑induced lung fibrosis. Experimental and Therapeutic Medicine.
Crossref
Crossref
Mark E. Morrey, Joaquin Sanchez‐Sotelo, Eric A. Lewallen, Kai‐Nan An, Diane E. Grill, Scott P. Steinmann, Jie J. Yao, Christopher G. Salib, William H. Trousdale, Nicolas Reina, Hilal M. Kremers, David G. Lewallen, Andre J. van Wijnen & Matthew P. Abdel. (2017) Intra‐articular injection of a substance P inhibitor affects gene expression in a joint contracture model. Journal of Cellular Biochemistry 119:2, pages 1326-1336.
Crossref
Crossref
Jun Bon Koo, Myeong-Ok Nam, Younshin Jung, Jongman Yoo, Duk Hwan Kim, Gwangil Kim, Sung Jae Shin, Kee Myung Lee, Ki Baik Hahm, Jong Woo Kim, Sung Pyo Hong, Kwang Jae Lee & Jun Hwan Yoo. (2017) Anti-fibrogenic effect of PPAR-γ agonists in human intestinal myofibroblasts. BMC Gastroenterology 17:1.
Crossref
Crossref
Jerome Avouac, Irena Konstantinova, Christophe Guignabert, Sonia Pezet, Jeremy Sadoine, Thomas Guilbert, Anne Cauvet, Ly Tu, Jean-Michel Luccarini, Jean-Louis Junien, Pierre Broqua & Yannick Allanore. (2017) Pan-PPAR agonist IVA337 is effective in experimental lung fibrosis and pulmonary hypertension. Annals of the Rheumatic Diseases 76:11, pages 1931-1940.
Crossref
Crossref
Eun-Jeong Kwon, Eun-Jung Park, Sungwook Choi, Sang-Rim Kim, Moonjae Cho & Jinseok Kim. (2017) PPARγ agonist rosiglitazone inhibits migration and invasion by downregulating Cyr61 in rheumatoid arthritis fibroblast-like synoviocytes. International Journal of Rheumatic Diseases 20:10, pages 1499-1509.
Crossref
Crossref
Yves Lecarpentier, Olivier Schussler, Victor Claes & Alexandre Vallée. (2017) The Myofibroblast: TGFβ-1, A Conductor which Plays a Key Role in Fibrosis by Regulating the Balance between PPARγ and the Canonical WNT Pathway. Nuclear Receptor Research 4.
Crossref
Crossref
Yue Hu, Liu-Lin Xiong, Piao Zhang & Ting-Hua Wang. (2016) Microarray expression profiles of genes in lung tissues of rats subjected to focal cerebral ischemia-induced lung injury following bone marrow-derived mesenchymal stem cell transplantation. International Journal of Molecular Medicine.
Crossref
Crossref
Yi Cheng, Chien-huang Lin, Jing-Yun Chen, Chien-Hua Li, Yu-Tin Liu & Bing-Chang Chen. (2016) Induction of Connective Tissue Growth Factor Expression by Hypoxia in Human Lung Fibroblasts via the MEKK1/MEK1/ERK1/GLI-1/GLI-2 and AP-1 Pathways. PLOS ONE 11:8, pages e0160593.
Crossref
Crossref
Caroline Lourenço de Lima, Michella Soares Coelho, Carine Royer, Augusto Pereira Resende, Gabriel Alvares Borges, Jaqueline Rodrigues da Silva, Angélica Amorim Amato, Eliete Guerra, Francisco de Assis Rocha Neves & Ana Carolina Acevedo. (2015) Rosiglitazone Inhibits Proliferation and Induces Osteopontin Gene Expression in Human Dental Pulp Cells. Journal of Endodontics 41:9, pages 1486-1491.
Crossref
Crossref
Kye-Im Jeon, Richard P. Phipps, Patricia J. Sime & Krystel R. Huxlin. (2015) Inhibitory effects of PPAR? ligands on TGF-?1-induced CTGF expression in cat corneal fibroblasts. Experimental Eye Research 138, pages 52-58.
Crossref
Crossref
Andr?a Tavares Dantas, Michelly Cristiny Pereira, Moacyr Jesus Barreto de Melo Rego, Laurindo Ferreira da Rocha, Ivan da Rocha Pitta, Cl?udia Diniz Lopes Marques, Angela Luzia Branco Pinto Duarte & Maira Galdino da Rocha Pitta. (2015) The Role of PPAR Gamma in Systemic Sclerosis. PPAR Research 2015, pages 1-12.
Crossref
Crossref
D Torrente, MF Avila, R Cabezas, L Morales, J Gonzalez, I Samudio & GE Barreto. (2013) Paracrine factors of human mesenchymal stem cells increase wound closure and reduce reactive oxygen species production in a traumatic brain injury in vitro model. Human & Experimental Toxicology 33:7, pages 673-684.
Crossref
Crossref
David Wolf, Nancy Tseng, Gregory Seedorf, Gates Roe, Steven H. Abman & Jason Gien. (2014) Endothelin-1 decreases endothelial PPARγ signaling and impairs angiogenesis after chronic intrauterine pulmonary hypertension. American Journal of Physiology-Lung Cellular and Molecular Physiology 306:4, pages L361-L371.
Crossref
Crossref
Zhen Ma, Youlu Pan, Wenhai Huang, Yewei Yang, Zunyuan Wang, Qin Li, Yin Zhao, Xinyue Zhang & Zhengrong Shen. (2014) Synthesis and biological evaluation of the pirfenidone derivatives as antifibrotic agents. Bioorganic & Medicinal Chemistry Letters 24:1, pages 220-223.
Crossref
Crossref
Chien-Huang Lin, Ming-Chih Yu, Wan-Hsuan Tung, Tzu-Ting Chen, Chung-Chi Yu, Chih-Ming Weng, Yan-Jyu Tsai, Kua-Jen Bai, Chuang-Ye Hong, Ming-Hsien Chien & Bing-Chang Chen. (2013) Connective tissue growth factor induces collagen I expression in human lung fibroblasts through the Rac1/MLK3/JNK/AP-1 pathway. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1833:12, pages 2823-2833.
Crossref
Crossref
Xiao-Feng Li, Jing Liao, Zhi-Qiang Xin, Wen-Qing Lu & Ai-Lin Liu. (2013) Relaxin attenuates silica-induced pulmonary fibrosis by regulating collagen type I and MMP-2. International Immunopharmacology 17:3, pages 537-542.
Crossref
Crossref
Se Jin Park, Young Joon Jun, Tae Hoon Kim, Jong Yoon Jung, Gyu Ho Hwang, Kwang Jin Jung, Seung Hoon Lee, Heung Man Lee & Sang Hag Lee. (2013) Increased Expression of YKL-40 in Mild and Moderate/Severe Persistent Allergic Rhinitis and its Possible Contribution to Remodeling of Nasal Mucosa. American Journal of Rhinology & Allergy 27:5, pages 372-380.
Crossref
Crossref
Keisuke Miyamoto, Sadatomo Tasaka, Yasushi Nakano, Hiromi Shinoda, Hirofumi Kamata, Wakako Yamasawa, Makoto Ishii, Naoki Hasegawa & Tomoko Betsuyaku. (2013) Differential Mechanisms of the Effect of Peroxisome Proliferator-Activated Receptor Gamma Agonists on Bleomycin-Induced Lung Fibrosis. Open Journal of Respiratory Diseases 03:02, pages 31-38.
Crossref
Crossref
A. Antonelli, C. Ferri, S.M. Ferrari, M. Colaci, I. Ruffilli, M. Sebastiani & P. Fallahi. (2013) Peroxisome proliferator-activated receptor ? agonists reduce cell proliferation and viability and increase apoptosis in systemic sclerosis fibroblasts. British Journal of Dermatology 168:1, pages 129-135.
Crossref
Crossref
Jihan A. Youssef & Mostafa Z. BadrJihan A. Youssef & Mostafa Z. Badr. 2013. Peroxisome Proliferator-Activated Receptors. Peroxisome Proliferator-Activated Receptors
33
69
.
Yanina Langle, Catalina Lodillinsky, Denise Belgorosky, Eduardo Omar Sandes & Ana Mar?a Eij?n. (2012) Role of Peroxisome Proliferator Activated Receptor-Gamma in Bacillus Calmette-Gu?rin Bladder Cancer Therapy. The Journal of Urology 188:6, pages 2384-2390.
Crossref
Crossref
Yi-Lei Deng, Xian-Ze Xiong & Nan-Sheng Cheng. (2012) Organ fibrosis inhibited by blocking transforming growth factor-β signaling via peroxisome proliferator-activated receptor γ agonists. Hepatobiliary & Pancreatic Diseases International 11:5, pages 467-478.
Crossref
Crossref
Ajit A. Kulkarni, Collynn F. Woeller, Thomas H. Thatcher, Sesquile Ramon, Richard P. Phipps & Patricia J. Sime. (2012)
Emerging PPAR
γ
-Independent Role of PPAR
γ
Ligands in Lung Diseases
. PPAR Research 2012, pages 1-13.
Crossref
Crossref
Kornelia Kis, Xiaoqiu Liu & James S. Hagood. (2011) Myofibroblast differentiation and survival in fibrotic disease. Expert Reviews in Molecular Medicine 13.
Crossref
Crossref